Information Provided By: 
Fly News Breaks for August 10, 2017
BIOS
Aug 10, 2017 | 07:11 EDT
As noted earlier, SunTrust upgraded BioScrip to Buy from Hold. As reasons for the upgrade, analyst David MacDonald cited "ongoing operational improvements, ramping collection/cash flow, solid conviction in new management's ability to execute and recent changes to the capital structure that removed an overhang." He also noted that the company's Q2 EBITDA and cash flow beat expectations, and he says that it could benefit from rate relief created by the Cure Act. Target to $3.75 from $3.25.
News For BIOS From the Last 2 Days
There are no results for your query BIOS
